Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/27/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Michael Haude

Wrong Dr. Michael Haude?

Director of Medical Clinic I

Local Address: Neuss, Germany

Employment History

  • Professor of Internal Medicine
  • Professor
  • Chief of Cardiology
    Stadtische Kliniken Neuss
  • Professor

Board Memberships and Affiliations

  • Director
    Medizinische Klinik I


  • M.D.
  • MD
44 Total References
Web References
"Late stent thrombosis is still a ..., 27 May 2013 [cached]
"Late stent thrombosis is still a concern for patients treated with monotherapy DES, leaving them dependent on a minimum of six months DAPT," said Michael Haude, M.D., director of Medical Clinic I at the Lukaskrankenhaus in Neuss, Germany, and principal investigator of the REMEDEE trial.
BIOTRONIK - Noticias - Comunicados de Prensa [cached]
The two-year clinical data results of BIOSOLVE-I for the BIOTRONIK Drug Eluting Absorbable Metal Scaffold were presented by Professor Michael Haude, MD Lukaskrankenhaus, Neuss, Germany, one of the study's investigators.
The results from the BIOSOLVE-I study were presented at the European Course on Revascularization in Paris (EuroPCR) by Professor Michael Haude, Lukaskrankenhaus, Neuss, Germany.
The dual therapy stent was shown ..., 29 Nov 2011 [cached]
The dual therapy stent was shown to be safe and effective, as well as non-inferior to the paclitaxel-eluting stent, according to lead researcher Michael Haude, Professor of Internal Medicine at Lukaskrankenhaus Neuss in Germany. Results of the REMEDEE trial were presented at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Visit Cardiology page. - Prog. Committee Members, 3 Jan 2014 [cached]
Michael Haude, Germany
Chief of Cardiology, St├Ądtische Kliniken, Neuss
He is Chairman of the Working Group on Interventional Cardiology of the German Societyof Cardiology.
Kensey Nash Corporation News Release, 18 June 2007 [cached]
Professor Michael Haude, M.D., Director of Medizinische Klinik I, Lukaskrankenhaus, Neuss, Germany, served as the principal investigator for the study, which took place in Germany.
"We were very pleased with the ThromCat(TM) System performance during the study. Not only did the system show itself to be safe and effective in removing thrombus in the coronary setting, it was also very easy to use. I am very appreciative of the power of this device particularly in the large coronary arteries. The device also appears to lessen the need for temporary pacing during these challenging procedures," commented Professor Haude.
Other People with the name "Haude":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.